Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000531562 | SCV000652074 | benign | Cutis laxa, autosomal recessive, type 1B | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001556936 | SCV001778609 | uncertain significance | not provided | 2022-05-19 | criteria provided, single submitter | clinical testing | In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge |
Mayo Clinic Laboratories, |
RCV001556936 | SCV004226188 | uncertain significance | not provided | 2023-05-04 | criteria provided, single submitter | clinical testing | BS1, PP3 |
Ambry Genetics | RCV004024217 | SCV005027196 | benign | Cardiovascular phenotype | 2020-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |